Human adenovirus e serotype 4 strain cl-68578 antigen

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Brand Names
Adenovirus Type 4 and Type 7 Vaccine, Live
Generic Name
Human adenovirus e serotype 4 strain cl-68578 antigen
DrugBank Accession Number
DB14409
Background

Human adenovirus e serotype 4 strain cl-68578 antigen is a vaccine.

Type
Biotech
Groups
Approved
Biologic Classification
Vaccines
Other vaccines
Synonyms
  • Adenovirus Type 4 Strain Cl-68578
  • Adenovirus Type 4 Vaccine Live
  • Adenovirus Vaccine, Live, Oral, Type 4
  • Human Adenovirus E Serotype 4 Strain Cl-68578
  • Human Adenovirus Serotype 4 Strain Cl-68578
  • Human Adenovirus Serotype 4 Vaccine Strain Cl-68578
  • Mastadenovirus Human Adenovirus B Type 4 Strain Cl-68578

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AbacavirThe therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Abacavir.
AbataceptThe risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Abatacept.
AcyclovirThe therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Acyclovir.
AdalimumabThe risk or severity of adverse effects can be increased when Adalimumab is combined with Human adenovirus e serotype 4 strain cl-68578 antigen.
Adefovir dipivoxilThe therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Adefovir dipivoxil.
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Adenovirus Type 4 and Type 7 Vaccine, LiveHuman adenovirus e serotype 4 strain cl-68578 antigen (32000 [TCID_50]/1) + Adenovirus type 7 vaccine live (32000 [TCID_50]/1)Kit; Tablet, coatedOralTeva Women's Health, Inc.2011-09-16Not applicableUS flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
FKD3DUK39I
CAS number
Not Available

References

General References
Not Available
RxNav
1099933

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Kit; tablet, coatedOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at July 05, 2018 18:02 / Updated at June 12, 2020 16:53